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Abstract 46 
Although  mouse infection  models  have been  extensively  used to  study the 47 
host response to Mycobacterium tuberculosis, their  validity in revealing 48 
determinants  of  human  TB resistance  and  disease  progression  has  been 49 
heavily  debated.  Here,  we  show that the  modular transcriptional  signature in 50 
the blood of susceptible mice infected with a clinical isolate of M. tuberculosis 51 
resembles that  of  active  human tuberculosis  disease,  with  a  dominance  of  a 52 
type I IFN response and neutrophil activation and recruitment, together with a 53 
loss in B lymphocyte, NK and T cel effector responses. In addition, resistant 54 
but  not  susceptible  strains  of  mice  show increased lung  B,  NK  and  T  cel 55 
efector responses in the lung upon infection. Importantly, the blood signature 56 
of  active  disease  shared  by  mice  and  humans is  also  evident in latent 57 
tuberculosis  progressors  before  diagnosis  suggesting that these responses 58 
both predict and contribute to the pathogenesis of progressive M. tuberculosis 59 
infection. 60 
 61 
Tuberculosis (TB) results in  over  1.3  milion  deaths  annualy1,  yet  most individuals 62 
infected  with M. tuberculosis remain  asymptomatic.  Latent  TB infection (LTBI) is 63 
defined  by  an interferon-γ (IFN-γ)-release  assay (IGRA)  specific for M. tuberculosis 64 
antigens , although some patients may have subclinical disease and may progress to 65 
active  TB2.  Protective immune responses  against M. tuberculosis include  CD4+  T 66 
lymphocytes and the cytokines IL-12, IFN-γ, TNF3-6, and IL-17, but these factors do 67 
not  explain  why  most individuals  control infection,  whereas  a  subset  go  on to 68 
develop  active  TB.  A  blood transcriptional  signature in  active  TB  patients  has 69 
implicated type I IFN in  TB  pathogenesis8-16. Immunological  heterogeneity in the 70 
blood transcriptome  of  a  cohort  of recent  TB  contacts  has  been  observed,  with  a 71 
smal  proportion  of  contacts  expressing  a  persistent  blood  TB  signature  and 72 
subsequently progressing to active disease (LTBI-progressors)16, suggesting a host 73 
response evolving towards active disease16. 74 
How the immune response in blood8,15 reflects that occuring at disease sites 75 
is poorly understood, and sampling the later in humans is prohibitive. The mouse TB 76 
model, owing to the richness of genetic and immunological tools available, has been 77 
invaluable in  defining immune responses in the lung influencing  disease  outcome 78 
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after infection4,5,17.  However,  a  global  systematic  analysis to  determine  potential 79 
common pathways of protection or pathogenesis in diferent TB mouse models and 80 
human disease has not been reported. A role for type I IFN in TB pathogenesis8-16 is 81 
supported by mouse TB models6,18 with elevated and sustained levels of type I IFN: 82 
(i) infection  of  particular  genetic  strains  of  mice  with  clinical isolates  of M. 83 
tuberculosis19-23; (i) infection  of  hosts  with  genetic  mutations in regulators  of type I 84 
IFN  such  as  Tpl224; IL-17  or ISG1525; (ii)  administration  of  adjuvants,  e.g. 85 
Poly(I)C7,26; or (iv) viral co-infection27. Whether it is the genetic strain of mouse or the 86 
M. tuberculosis pathogen itself  which results in  an immune response that  most 87 
resembles human TB is unclear. Although the spectra of human28 and mouse29 TB 88 
disease do not completely overlap, comparison of human TB with geneticaly diverse 89 
backgrounds  of  mice  has  established  points  of  similarity in their response to M. 90 
tuberculosis. Some mouse strains recapitulate key elements of the pathogenesis of 91 
human  TB  disease,  at the level  of induction  of  necrotic  TB lesions in the lungs29. 92 
Whether the global immune response to M. tuberculosis in susceptible mouse strains 93 
resembles that of TB in humans is as yet unclear. 94 
Here, we report that the human blood TB type I IFN-inducible signature16,8 is 95 
recapitulated in  susceptible  C3HeB/FeJ  mice infected  with  diferent  strains  of M. 96 
tuberculosis. Increased  expression  of  granulocyte-associated  genes in  blood from 97 
active  TB  patients,  TB-susceptible  mice and  LTBI-progressors before  TB diagnosis 98 
suggested their role in early disease pathogenesis. Conversely, under-abundance of 99 
B,  NK  and  efector  T  cel-signatures in  blood from  human  TB  patients16,  LTBI-100 
progressors  and  TB-susceptible  mice  and  yet  over-abundance in lungs  of M. 101 
tuberculosis infected  C57BL/6J resistant  mice reinforced their role in  early  disease 102 
control.  The translationaly relevant  knowledge  dataset  presented  here  on  potential 103 
pathways  of  protection  and  pathogenesis in  human  TB  are  easily  accessible  using 104 
an online  ShinyApp : https://ogarra.shinyapps.io/tbtranscriptome/ 105 
 106 
RESULTS 107 
The  peak transcriptomic response in M. tuberculosis infected  mice.  To 108 
determine if  a  mouse  blood transcriptional  TB  signature resembles that  of  human 109 
disease, we tested the human blood modular transcriptional TB signature16 on RNA-110 
Seq data from blood of diferent genetic inbred strains of mice, C57BL/6J (resistant) 111 
and  C3HeB/FeJ (susceptible), infected  with low  and  high  doses  of the M. 112 
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tuberculosis laboratory  strain H37Rv  or  clinical isolate  HN87821,22 (Supplementary 113 
Fig.1a-c;  Fig.  1,  Supplementary  Tables  1-3).  The  human  blood  TB  signature16  was 114 
first tested on microaray data from blood of H37Rv infected BALB/c mice at diferent 115 
time-points  post-infection, to  establish the  peak transcriptomic response,  where 116 
immune  signatures  were  barely  detectable  at  days  14  and  21  post-infection,  but 117 
most  significant  by  day  138 (Supplementary  Fig.  2a;  Supplementary  Table  3). 118 
Analysis  of  blood  microaray  data from  an independent  study30,  showed that the 119 
blood signature in 129S2 and C57BL/6NCrl mice was again barely detectable at day 120 
14  post  H37Rv infection,  being  observed robustly  by  day  21,  which  was the  end-121 
point of that study30 (Supplementary  Fig.  2a).  Upon testing  a lung disease  modular 122 
signature31  on  microaray  data from lungs  of  H37Rv infected  BALB/c  mice,  we 123 
detected a peak response at day 56 post-infection, only starting to be detected by 28 124 
days  post-infection (Supplementary  Fig.  2b;  Supplementary  Table  4).  Based  on 125 
these  data  we tested the  human  blood transcriptional  TB  signature16  and lung 126 
disease  modular  signature31,  on the  blood  and lungs, respectively, from  C57BL/6J 127 
and  C3HeB/FeJ  mice infected  with  HN878,  at  days  26 to  56  post-infection 128 
(Supplementary Fig. 3a and b; Supplementary Tables 3 and 4). The peak response 129 
chosen  was  ca.  42  days  post-infection,  which  best  showed  a robust  signature in 130 
blood  and lungs from  HN878 infected  C57BL/6J  and  C3HeB/FeJ  mice 131 
(Supplementary Fig. 3a and b; Supplementary Tables 3 and 4; tissues from HN878 132 
infected  susceptible  mice  were  harvested  after  33-35  days  post infection  due to 133 
excessive pathology). 134 
 135 
Blood transcriptional TB signature in mouse and humans. Principal component 136 
analysis (PCA)  at the  peak response  depicted  distinct  global transcriptional 137 
signatures in  blood  of  C57BL/6J (resistant)  and  C3HeB/FeJ (susceptible)  mice, 138 
infected with low and high doses of H37Rv or HN878, with the largest distance from 139 
uninfected mice observed in HN878 infected C3HeB/FeJ mice (Supplementary Fig. 140 
1c).  The  human  blood  modular transcriptional  TB  signature16  was recapitulated in 141 
blood of HN878 infected C3HeB/FeJ mice, and high dose HN878 infected C57BL/6J 142 
mice (Fig.  1; for  annotation  see  Supplementary  Table  1; for  genes  see 143 
Supplementary  Tables  2  and  3).   Two  over-abundant (red) IFN-inducible  modules 144 
(HB12 and  HB23) in blood from TB  patients16,  showed a graded increase from the 145 
C57BL/6J to the  C3HeB/FeJ  mice infected  with low to  high  dose  H37Rv, further 146 
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increased in C57BL/6J then C3HeB/FeJ mice infected with low to high dose HN878 147 
(Fig.  1).  Expression levels  of IFN-inducible  modules (HB12  and  HB23), in  blood  of 148 
HN878 infected  C3HeB/FeJ  mice  most  closely resembled the  profile in  human  TB 149 
(Fig.  1).  Likewise,  other  over-abundant  modules  of  human  TB, including 150 
Inflammasome (HB3), Innate/hemopoietic mediators (HB5), Innate immunity/PRR/C’ 151 
(HB8) and Myeloid/C’/Adhesion (HB14) modules, were over-abundant in the HN878 152 
infected  C3HeB/FeJ  mice,  and to  a lesser  extent in  high  dose  HN878 infected 153 
C57BL/6J  mice (Fig.  1).  Under-abundance (blue)  of the  human TB  modules,  T  cel 154 
(HB4)  and  B  cel (HB15)16,  was recapitulated in the  blood  of  HN878 infected 155 
C3HeB/FeJ  mice (Fig.  1). In  keeping  with this,  celular  deconvolution  analyses31  of 156 
blood  RNA-seq  data from M. tuberculosis infected  mice  showed  a  significant 157 
decrease in the percentages of B cel and CD4+ T cel fractions (Supplementary Fig. 158 
1d). 159 
  Cel-types associated with each module were identified by comparing cel-type 160 
specific gene signatures using the mouse RNA-Seq dataset from ImmGen Ultra Low 161 
Input (ULI) (ImmGen  Consortium -  GSE109125; htp:/www.immgen.org)  as 162 
described31, analysed against the mouse gene orthologues within each human blood 163 
TB module (Fig. 1, right panel). The cel-type specific enrichment data validated the 164 
modular annotation for the blood T cel (HB2, HB4) modules, with enrichment for αβ- 165 
and γδ-T cels; the NK and T cel (HB21) module, with enrichment for αβ- and γδ-T 166 
cels  and innate lymphocytes;  and the  B  cel (HB15)  module  with  enrichment for  B 167 
cels (Fig.  1).  This  approach  also led to the  discovery  of  previously  unappreciated 168 
gene  signatures,  most  strikingly,  a  dominance  of  granulocyte-associated  genes 169 
within the Inflammasome (HB3) and Innate immunity/PRR/C’ (HB8) modules (Fig. 1). 170 
This set of granulocyte-associated genes was highly expressed in blood from HN878 171 
infected C3HeB/FeJ mice and human TB cohorts (Table 1; Supplementary Table 3 172 
Mouse;  Supplementary  Table  2  Human). Increased  expression  of  granulocyte-173 
associated  genes in  blood  of  HN878 infected  C3HeB/FeJ  mice  was reinforced  by 174 
data obtained from celular deconvolution analyses31(Supplementary Fig. 1d). 175 
 176 
Host  and M. tuberculosis genetic  differences  drive lung  TB  signatures. To 177 
determine the transcriptional response  at the  site  of infection,  RNA-Seq  data  was 178 
obtained from the lungs  of the  same  C57BL/6J  and  C3HeB/FeJ inbred  strains  of 179 
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mice infected  with  H37Rv  or  HN878,  used for the  blood  data from  Fig.  1 180 
(Supplementary  Fig.  1a).  PCA  depicted  distinct  global transcriptional  signatures for 181 
uninfected mice and the diferent strains of H37Rv or HN878 infected mice, with the 182 
largest  distance from  uninfected  controls  observed in  HN878 infected  C3HeB/FeJ 183 
mice (Supplementary  Fig.  4).  The lung transcriptional response  depicted  a  similar 184 
but more accentuated diference between the infected and uninfected groups than in 185 
blood (Supplementary Fig. 1c and Supplementary Fig. 4). 186 
 A lung  disease  modular  signature31  was tested  on the lung  RNA-Seq  data 187 
from the diferent groups of infected mice, to identify co-expressed groups of genes 188 
across the lung (Fig.  2).  The type I IFN/Ifit/Oas (L5)  module  was  over-abundant in 189 
the lungs of  H37Rv and  HN878 infected  C57BL/6J and  C3HeB/FeJ mice to similar 190 
levels, as shown by Eigengene expression (Fig. 2a and b). Six modules (L10 – L15), 191 
dominated by an over-abundance of granulocyte, macrophage and myeloid specific 192 
genes, including  modules  with  Myeloid/Granulocyte (L10)  and IL-17 193 
pathway/Granulocytes (L11) function,  showed the  highest  Eigengene  expression in 194 
the  HN878 infected  C3HeB/FeJ  mice (Fig.  2a  and  c; ShinyApp;  Supplementary 195 
Table  4).   Similarly, the Inflammation/IL-1  signaling/Myeloid  Cels (L12),  Myeloid 196 
cels/Il1b/Tnf (L13) and Myeloid cels/Other signaling (L14) modules were also over-197 
abundant in mouse lungs upon M. tuberculosis infection, particularly in the lungs of 198 
susceptible  HN878 infected  C3HeB/FeJ  mice (Fig.  2;  Supplementary  Table  4). 199 
Strikingly,  an Immunoglobulin  h/k  module (L25)  was  over-abundant in the lungs  of 200 
the  C57BL/6J  but  only  minimaly in  C3HeB/FeJ  mice infected  with low  and  high 201 
doses of H37Rv, and in the lungs of low dose HN878 infected C57BL/6J mice (Fig. 202 
2a  and  d; ShinyApp;  Supplementary  Table  4).  However, this Immunoglobulin  h/k 203 
(L25) module was not changed in the lungs of high dose HN878 infected C57BL/6J 204 
mice  or  C3HeB/FeJ  mice (Fig.  2a  and  d),  correlating  with these  mice  showing 205 
greater  TB  susceptibility (Supplementary  Fig.  1b).  This Immunoglobulin  h/k (L25) 206 
module was also highly abundant in the lungs of BALB/c mice infected with low dose 207 
H37Rv, in  keeping  with its relatively resistant  phenotype (Supplementary  Fig.  2b). 208 
The Ifng/Gbp/Ag presentation/C’ (L7) and Cytotoxic/T cels/ILC/Tbx21/Eomes/B cels 209 
(L35)  modules  were  over-abundant in the lung  across  both  strains  of  H37Rv  or 210 
HN878 infected  mice (Fig.  2a  and  e;  Supplementary  Fig.  3b),  and  H37Rv infected 211 
BALB/c  mice (Supplementary  Fig.  2b),  but less  abundant in lungs from  HN878 212 
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infected C3HeB/FeJ mice (Fig. 2a; Supplementary Fig. 3b), as shown quantitatively 213 
by Eigengene profiles (Fig. 2e). 214 
Independent derivation and annotation yielded similar transcriptional modules 215 
across al samples from uninfected and M. tuberculosis infected mice, resulting in 27 216 
modules ((ML1 – ML27), Supplementary Fig. 5; Supplementary Tables 5 and 6). The 217 
type I IFN/Stat2/Mx1 (ML2) and type I IFN signaling (ML21) modules were similarly 218 
over-abundant in the lungs of H37Rv and HN878 infected C57BL/6J and C3HeB/FeJ 219 
mice (Supplementary Fig. 5a and b). Over-abundance of modules ML19 and ML27, 220 
enriched for  Granulocyte/Macrophage  specific  genes,  showed  highest  Eigengene 221 
expression in  HN878 infected  C3HeB/FeJ  mice (Supplementary  Fig.  5a  and  c), 222 
confirmed  by  cel-type  specific  enrichment  analysis (Supplementary  Fig.  5a).  The 223 
Ifng/Gbp/Ag  presentation/C’ (ML3)  and  T  cel/NK/ILC/APC/B  cel (ML11)  modules 224 
were  over-abundant in lungs from  both  strains  of  H37Rv  or  HN878 infected  mice, 225 
although significantly less abundant in HN878 infected C3HeB/FeJ mice,  as shown 226 
quantitatively by Eigengene profiles (Supplementary Fig. 5a and d), and validated by 227 
cel-type  specific  enrichment for  T  cels,  DC, innate lymphocytes (ILC)  and  B  cels 228 
(Supplementary  Fig.  5a).  Thus, two  complementary  and independently  derived 229 
modular tools revealed  similar transcriptional  signatures in the lungs  of M. 230 
tuberculosis infected  susceptible  mice, indicating increased type I IFN  and 231 
granulocyte-associated responses  and  decreased IFN-γ,  NK,  T  efector  and  B  cel 232 
responses (Fig. 2 and Supplementary Fig. 5). 233 
The  over-abundance  of inflammatory  modules  associated  with  granulocytes 234 
observed using the two independent modular approaches is in keeping with the more 235 
severe inflammation  observed  by  H&E  staining in the lungs  of  HN878 infected 236 
C3HeB/FeJ  mice  and  high  dose  HN878 infected  C57BL/6J  mice (Fig.  3; 237 
Supplementary  Fig.  6).  This  was  accompanied  by  greater  numbers  of M. 238 
tuberculosis bacteria  observed in the lungs  of these  mice  by  ZN  staining 239 
(multibacilary infections, Fig. 3; Supplementary Fig. 6). 240 
 241 
Degree  of  preservation  of lung  modules in  human  and  mouse  blood. It is 242 
unclear to  what  extent the  airway transcriptional  signature is reflected in the  blood 243 
during M. tuberculosis infection.  Certain immune responses  across  a range  of 244 
experimental  models of  disease are  wel  preserved  between lung  and  blood,  some 245 
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not  preserved,  and  others  only  discernible in  blood  with  prior  knowledge from the 246 
airway response31.  To  address this  question in  TB, the  mouse lung  modular  TB 247 
signature (Supplementary  Fig.  5a)  was tested  on the  RNA blood  samples from the 248 
diferent  cohorts  of  human  TB  patients  and from the  diferent  mouse  TB  models 249 
(Supplementary Fig. 7a). The mouse lung modules showed significant preservation 250 
in human and mouse blood as assessed by Zsummary scores, indicating the degree of 251 
preservation, with scores >10 considered strongly preserved (Supplementary Fig. 7b 252 
and  c).  Type I IFN  associated  modules (ML2  and  ML21) (Supplementary  Fig.  5a), 253 
were  over-abundant in  human  and  mouse  blood,  being  most  over-abundant in 254 
HN878 infected  susceptible  mice (Supplementary  Fig.  7a).  The lung type I 255 
IFN/Stat2/Mx1 module (ML2) was the most highly preserved module in human blood 256 
(Supplementary  Fig.  7b)  and the  second-most  preserved  module in  mouse  blood 257 
(Supplementary  Fig.  7c)  and the type I IFN  signaling  module (ML21)  stood  out  as 258 
the third-most  preserved  module in  both  human  and  mouse  blood (Supplementary 259 
Fig. 7b and c). The lung Ifng/Gbp/Ag presentation/C’ module (ML3) was weakly over-260 
abundant in the  blood  of  human  TB  patients  and M. tuberculosis infected  mice 261 
(Supplementary  Fig.  7a),  albeit to  a lesser  extent,  but  highly  preserved in  both 262 
human  and  mouse  blood (Supplementary  Fig.  7b  and  c).  The  overal increased 263 
abundance of the Ifng/Gbp/Ag presentation/C’ module (ML3) was largely atributable 264 
to  over-expression  of  genes  such  as  GBP/Gbp  genes  and  complement  genes 265 
(Supplementary  Fig.  7a;  Supplementary  Tables  2  and  3,  and ShinyApp).  However, 266 
the Ifng  gene itself,  although  upregulated in the  blood  of M. tuberculosis infected 267 
resistant  mice,  was  barely  upregulated in the  blood  of  HN878 infected  susceptible 268 
mice and IFNG  was  down-regulated in the  blood from  TB  patients (Supplementary 269 
Tables 2 and 3, and ShinyApp). The lung Macrophage/Granulocyte modules (ML19 270 
and  ML27)  and  Myeloid  cel  signaling  module (ML10)  were  also  over-abundant in 271 
blood of active TB patients and most over-abundant in the blood of HN878 infected 272 
susceptible  mice (Supplementary  Fig.  7a).  While lung  ML19  and  ML10  modules 273 
were highly preserved in both human and mouse blood, the ML27 module was only 274 
highly  preserved in  mouse  blood  and to  a  much lesser  extent in  human 275 
(Supplementary  Fig.  7b  and  c).  Lung  modules  associated  with  T,  NK  and  B  cels 276 
(ML11  and  ML13)  were  over-abundant in the lungs  of  al relatively resistant  mice 277 
infected  with  H37Rv,  but to  a lesser  extent (ML11)  or  under-abundant (ML13) in 278 
HN878 infected susceptible mouse lungs (Supplementary Fig. 5) and blood from al 279 
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TB  cohorts (Supplementary  Fig.  7a),  ML11  being  highly  preserved in  both  human 280 
and  mouse  blood (Supplementary  Fig.  7b  and  c).  These findings regarding the 281 
preservation  of  over  or  under-abundant lung  modules in the  blood from  human  TB 282 
patients  and  TB  susceptible  mouse  models (Supplementary  Fig.  7),  are in  keeping 283 
with the transcriptional signatures observed on testing human blood TB modules on 284 
blood from humans and mouse models of TB (Fig. 1). 285 
 286 
Modular gene networks in human versus mouse TB. We further interrogated the 287 
changes in gene expression of the key modules, HB3, HB15 and HB21, between the 288 
blood and lungs of resistant and susceptible mice infected with the diferent strains of 289 
M. tuberculosis, as  compared to the  human  blood.  To  do  so,  we  examined the 290 
expression  of top  50 “hub”  genes  with  high intramodular  connectivity  within the 291 
mouse  data,  on  human  blood from  TB  patients,  and  blood  and lungs from  mice 292 
infected  with M. tuberculosis (Fig.  4). In  keeping  with  our  curent findings that 293 
granulocyte  specific  genes  are  upregulated  within the  originaly  named 294 
Inflammasome  human  blood  TB  module (HB3)16,  granulocyte-specific  genes  were 295 
amongst the 50 “hub” genes within that module (now “Inflammasome/Granulocyte”) 296 
(Fig. 4). These granulocyte-specific genes include, Cd177, Elane, Mmp8, Mpo, Ncf1, 297 
Camp,  Lcn2,  S100a6,  Ltf (Fig.  4,  Supplementary  Fig.  8a; ShinyApp), which  have 298 
been  associated  with  neutrophil recruitment  and  activation32,  were  most  highly 299 
diferentialy  expressed in  blood from  TB  patients  and M. tuberculosis infected 300 
susceptible mice . Expression of these genes in mouse blood and lungs revealed a 301 
graded increase from the C57BL/6J to the C3HeB/FeJ mice infected with low to high 302 
dose H37Rv, with a further increase observed in C57BL/6J to the C3HeB/FeJ mice 303 
infected with low to high dose HN878 (Fig. 4, Supplementary Fig. 8a). The 50 “hub” 304 
genes  within Innate immunity/PRR/C’  module (HB8)  also  showed  enrichment for 305 
granulocyte-specific  genes including Mmp9,  Alox5ap,  Ncf2,  Mxd1,  S100a8 and 306 
S100a9, also  associated  with  neutrophil  activation (Supplementary  Fig.  8b),  and 307 
were  most  highly  expressed in  blood from  human  TB  patients  and  blood  and lung 308 
from  HN878 infected  C3HeB/FeJ  mice (Fig.  4,  Supplementary  Fig.  8b; ShinyApp). 309 
Increased  expression  of these  neutrophil-specific  genes in the lungs  of the  TB 310 
susceptible  HN878 infected  mice  was  mirrored  by the increased  numbers  of 311 
neutrophils  detected in the lungs  of these  mice  by immunohistochemistry (Fig.  5; 312 
Supplementary  Fig.  6),  confirming the  H&E  data (Fig.  3;  Supplementary  Fig.  6). 313 
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Colectively these  data  support  a  major role for  neutrophils in  human  TB 314 
pathogenesis, similar to the previously reported role for neutrophils in TB susceptible 315 
strains of mice33-35. 316 
  The 50 top “hub” genes within the human B cel module (HB15), Cd19, Pax5, 317 
Spib, Cd79 and Cd22, were down-regulated in the blood of human TB patients and 318 
M. tuberculosis mice (Fig. 4; Supplementary Fig. 8c; ShinyApp). Most of the B cel-319 
specific top “hub” genes were upregulated in the lungs of H37Rv infected mice, but 320 
strikingly  down-regulated in the lungs  of  high  dose  HN878 infected  C57BL/6J  and 321 
C3HeB/FeJ  mice (Fig.  4;  Supplementary  Fig.  8c; ShinyApp).  This  diference in 322 
expression of B cel-specific genes between the lungs of relatively TB resistant and 323 
susceptible  mouse  models,  was  mirrored  by  diferences in the  numbers  of  B  cels 324 
detected by B cel-specific immunofluorescent staining of lungs from these mice (Fig. 325 
5; Supplementary Fig. 6). While vastly increased numbers of B cels were observed 326 
in the lungs of H37Rv infected mice, with accompanying formation of B cel folicles, 327 
these were practicaly absent in the lungs of C57BL/6J mice infected with high dose 328 
HN878 and HN878 infected C3HeB/FeJ mice (Fig. 5; Supplementary Fig. 6). These 329 
data support a possible role for B cels in protection against M. tuberculosis infection, 330 
as has previously been proposed36,37. 331 
 In  keeping  with the  under-abundance  of the  human  blood  NK  &  T  cels 332 
module (HB21), the top  50 “hub”  genes in this  module  were  down-regulated in the 333 
blood  of  patients  with  active  TB (Fig.  4;  Supplementary  Fig.  8d),  as  previously 334 
reported16. Although upregulated in the blood and lungs of H37Rv infected C57BL/6J 335 
and C3HeB/FeJ mice and HN878 infected C57BL/6J mice, the majority of these 50 336 
“hub”  genes  were  down-regulated in the  blood  and  either  minimaly  or  not 337 
upregulated in the lungs from  HN878 infected  C3HeB/FeJ  mice (Fig.  4; 338 
Supplementary Fig. 8d). These included Tbx21, Gzma, Eomes, Cd8a, Nfatc2, Fasl, 339 
Nkg7,  Klrd1, Klrg1, Ifng and Runx3, reflecting downregulation of efector  T and NK 340 
cels in the  blood  of  TB  patients  and  HN878 infected  C3HeB/FeJ  mice (Fig.  4; 341 
Supplementary Fig. 8d; ShinyApp). Minimaly altered gene expression was mirored 342 
by a decrease in CD3+ T cels in HN878 infected C3HeB/FeJ mouse lungs as shown 343 
by immunofluorescence (Fig.  5;  Supplementary  Fig.6), reflecting  an  absence  of 344 
activated efector T cels required for protection against M. tuberculosis infection4-6. 345 
Heatmaps  of the top  50 “hub”  genes from the  human  blood  TB  modules 346 
Interferon/PRR (HB12)  and Interferon/C’/Myeloid (HB23)  demonstrated  a large 347 
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number  of  genes that  were  over-expressed in  human  blood from  London  and 348 
Leicester TB cohorts and were similarly over-expressed in mouse blood from HN878 349 
infected C3HeB/FeJ mice (Supplementary Fig. 9). In contrast, many of these type I 350 
IFN-inducible genes in the HB12 module, including Il1rn, Ifit1, Ifit2, Oas2 and Stat2, 351 
were  not  upregulated,  or  upregulated to  a lower  extent, in the  blood  of  H37Rv 352 
infected  C57BL/6J  mice,  as  compared to  HN878 infected  C3HeB/FeJ  mice 353 
(Supplementary  Fig.  9).  The  majority  of the top  50 “hub”  genes from the 354 
Interferon/PRR (HB12)  and Interferon/C’/Myeloid (HB23)  human  modules  were 355 
upregulated in the lungs  of  al the M. tuberculosis infected  mice,  with the  highest 356 
expression  observed in the lungs from  HN878 infected  C3HeB/FeJ  mice 357 
(Supplementary Fig. 9). 358 
 359 
Blood signatures reflect the extent of lung pathology in TB. Correlation between 360 
the whole blood TB signature and the extent of lung radiographic burden of human 361 
disease has been reported8. A quantitative measure of the transcriptional signature, 362 
determined using the molecular distance to health, showed a graded increase in the 363 
signature  across  patients  categorised  with  no  disease to  minimal,  moderate  and 364 
advanced  disease8.  Here  we  show that the  extent  of the  blood  modular  signatures 365 
associated  with type I IFN-inducible  genes (HB12  and  HB23),  shown  quantitatively 366 
by  Eigengene  expression,  positively  corelated  with the  extent  of lung  pathology 367 
assessed by the combined relative lesion burden and percentage of tissue afected 368 
scores in the TB mouse models (Fig. 6a). The type I IFN-associated blood modular 369 
signature was lowest in the more resistant mouse models of TB increasing with the 370 
diferent levels  of lung  pathology,  peaking in the  HN878 infected  C3HeB/FeJ  mice 371 
(Fig. 6a). Similarly, the level of the type I IFN-associated blood modular signatures in 372 
human TB , here shown by Eigengene expression, also positively correlated with the 373 
radiographic extent of lung disease in patients with diferent degrees of disease (Fig. 374 
6b).  The  neutrophil-associated (HB3  and  HB8)  blood  modular  signatures, likewise, 375 
showed an increased Eigengene expression in the blood of mice in the diferent TB 376 
models  corelating  with  an increased lung  neutrophil  score (Fig.  6c),  and the  most 377 
severe lung lesions  as  assessed  histopathologicaly (Fig.  6a).  The  neutrophil-378 
associated modular blood signature was highest in the HN878 infected C3HeB/FeJ 379 
mice  correlating  with the  highest lung  neutrophil  score (Fig.  6c).  Although the 380 
neutrophil lung score was similarly high in the high dose HN878 infected C57BL/6J 381 
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mice, the blood neutrophil-associated modular signature remained low in these mice 382 
(Fig.  6c).  The  blood  neutrophil-associated  signature in  human  TB  also  positively 383 
correlated with the radiographic extent of lung disease in TB patients (Fig. 6d), again 384 
supporting a role for neutrophils in TB pathogenesis. 385 
In  contrast to the increased type I IFN  and  neutrophil-associated  blood 386 
modular signatures in TB, the blood B cel (HB15) and NK & T cel (HB21) modular 387 
signatures showed a decrease in the blood of M. tuberculosis infected mice showing 388 
advanced lung disease,  specificaly the HN878 infected  C3HeB/FeJ mice, and to a 389 
lesser extent the high dose HN878 infected C57BL/6J mice (Fig. 6e). This decreased 390 
blood  signature in  advanced  disease  corelated  with  a  decrease in the lung 391 
lymphocyte  score,  which in the  more resistant  mice  had increased  upon infection 392 
(Fig. 6e). In human TB, these blood B cel (HB15) and NK & T cel (HB21) modular 393 
signatures  showed  a  similar  decrease in the  blood, inversely  corelating  with the 394 
extent of lung radiographic disease (Fig. 6f). 395 
 396 
Modular  blood  signatures in  LTBI-progressors. We  next  set  out to  determine 397 
whether the type I IFN (HB12, HB23), neutrophil (HB3, HB8), B cel (HB15) and NK 398 
& T cel (HB21) associated modular signatures, determined in human active TB and 399 
susceptible  mouse  models  of  TB,  could  be  detected  during  early M. tuberculosis 400 
infection of humans. To this end, we analysed our RNA-Seq data from the blood of 401 
recent contacts of active TB patients who were subsequently shown to progress to 402 
active  TB (LTBI-progressors),  active TB  patients  and  healthy  controls (IGRA-ve  and 403 
IGRA+ve contacts who did not progress to TB)16 (Fig. 7). 404 
The Interferon/PRR (HB12)  and Interferon/C’/Myeloid (HB23)  blood  modular 405 
signatures,  shown  quantitatively  by  Eigengene  expression,  were increased in the 406 
blood of LTBI-progressors to the same level as in active TB patients, as compared to 407 
healthy controls (Fig. 7a). As shown for the London cohort (Fig. 6b), the type I IFN-408 
associated  modular  signatures  also  correlated  with the radiographic  extent  of lung 409 
disease in this independent  cohort (Fig.  7a).  Type I IFN-inducible  genes in these 410 
modular  signatures included STAT1,  STAT2, IRF9,  OAS1,  OASL, IFITM1, ISG15 411 
and IL1RN  which  were  expressed  at  same level in the  blood  of  LTBI-progressors 412 
and active TB patients (Fig. 8a; ShinyApp). Again, the degree of expression of these 413 
individual  genes  positively  corelated  with the  extent  of radiographic  signs  of 414 
disease, being already increased in the blood of patients with minimal disease (Fig. 415 
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8a).  We  also  observed increased  expression  of these type I IFN-inducible  genes 416 
(Fig. 8a) in an independent cohort of LTBI-progressors, as compared to individuals 417 
with LTBI who remained healthy38. 418 
  Strikingly,  expression  of the  neutrophil-associated (HB3  and  HB8)  modular 419 
signatures was also increased to high levels in the blood of LTBI-progressors, to the 420 
same level as seen in blood of active TB patients, as compared to healthy controls 421 
(Fig.  7b).  The  extent  of these  neutrophil  associated  blood  signatures  positively 422 
correlated  with the radiographic  signs  of lung  disease (Fig.  7b).  Confirming the 423 
contribution of genes associated with neutrophil activation and recruitment, CD177, 424 
NCF1,  NCF2,  LRG1,  MMP9,  S100A8,  S100A9 and ALOX5AP were  upregulated in 425 
the  blood  of  LTBI-progressors from  both  cohorts,  as  compared to  controls to  a 426 
similar level as in the blood of active TB patients, their level of expression corelating 427 
with increased  signs  of radiographic lung  disease (Fig.  8b).  The increased 428 
expression  of  genes  associated  with  neutrophil  activation  and recruitment in the 429 
blood  of  TB  patients  with  minimal radiographic  signs  of  disease  and  LTBI-430 
progressors (Fig. 8b) points to an unappreciated role for neutrophils in early disease. 431 
  The  expression  of the  B  cel (HB15)  and  NK  &  T  cel (HB21)  associated 432 
modular  signatures  was  decreased in the  blood  of  LTBI-progressors to the  same 433 
extent  as in  active  TB (Fig.  7c),  as  compared to  controls,  again  correlating  with 434 
increased radiographic  signs  of  disease (Fig.  7c).  Expression  of the  NK  &  T  cel 435 
specific  genes IFNG,  EOMES,  TBX21,  GZMA,  KLRD1,  NKG7, was  similarly 436 
decreased in the  blood  of  LTBI-progressors in  both  cohorts,  as  compared to the 437 
healthy controls and in the blood of patients with minimal signs of disease, although 438 
further  decreased in those  with  advanced  signs  of radiographic  disease (Fig.  8c). 439 
Since T cel and NK cel genes convey protection against M. tuberculosis infection4-440 
6,39,40, their loss may contribute to progression to active TB. 441 
  Colectively  our findings  predict that  a  dominance  of  gene  expression 442 
associated  with  a type I IFN response  and  neutrophil  activation  and recruitment, 443 
together with a loss of NK and T cel efector responses, early after infection with M. 444 
tuberculosis, may contribute to progression to active TB. 445 
 446 
DISCUSSION 447 
Here  we  show that the IFN-inducible  human  blood  TB transcriptional  signature16 is 448 
recapitulated in  blood from M. tuberculosis HN878 infected  TB  susceptible 449 
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C3HeB/FeJ  mice,  whereas this  signature is  minimal in  blood from  M. tuberculosis 450 
H37Rv infected resistant C57BL/6J mice. Combining our modular signature data with 451 
cel-type specific signatures31 we reveal an increase in neutrophil-associated genes 452 
in the blood  of TB  susceptible mice  and TB  patients.  Genes associated with type I 453 
IFN responses  and  with  neutrophil recruitment  and  activation  were increased in 454 
LTBI-progressors before diagnosis, suggesting an unappreciated role for neutrophils 455 
in early disease. Decreased B, NK and T cel-signatures of human active TB8,16 were 456 
observed in the blood of infected TB susceptible mice and LTBI-progressors, whilst 457 
upregulated  upon infection in the lungs  of  TB resistant  mice,  suggesting that their 458 
early loss contributes to progression to active TB. 459 
Neutrophils  are  abundant in the lung lesions  of M. tuberculosis infected 460 
susceptible  mice  contributing to  TB  pathogenesis33,34  whereas lesions  of infected 461 
resistant mice contain only scatered neutrophils, instead dominated by lymphocytes 462 
and macrophages41. M. tuberculosis infected neutrophils have been detected within 463 
inflammatory lung  granulomas  of  patients  with  active  TB42,43.  We  herein reveal low 464 
levels  of  a  neutrophil-associated  signature in lungs  of M. tuberculosis infected 465 
C57BL/6J  mice,  which  was  maximaly increased in  HN878 infected  susceptible 466 
C3HeB/FeJ  mice.  This  was  validated  by  histological  analysis,  although  S100A9 467 
neutrophil staining was lost due to the necrotic nature of the lesions. This led to our 468 
discovery  of increased  expression  of  neutrophil-associated  genes  within the  over-469 
abundant  human  TB  blood  modules,  originaly  annotated  as “Inflammasome”  and 470 
“Innate immunity/PRR/C’”16, which we now rename as “Inflammasome/Granulocyte” 471 
and “Innate immunity/PRR/C’/Granulocyte”. Previous studies showed no change by 472 
flow cytometry in neutrophil numbers in the blood of active TB patients8, suggesting 473 
that the  over-abundance  of this  granulocyte-associated  signature  of  activation  and 474 
recruitment  may  be  atributable to  a  subset  of  activated  neutrophils  which  have 475 
circulated to the  blood from the lung.  Whether these  neutrophils  are  cariers  of M. 476 
tuberculosis to the blood in human TB, where the bacteria have been recently shown 477 
to  be  detected in  early  disease44, remains to  be investigated.  This  granulocyte-478 
associated  signature  was  also increased in  blood from  LTBI-progressors  before 479 
diagnosis,  suggesting  a  previously  unappreciated role for  neutrophils in  early 480 
progression to disease. 481 
  The type I IFN-associated  signature  widely reported in  blood  of  active  TB 482 
patients8-16  was  also  present in  blood from M. tuberculosis infected  mice,  with the 483 
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highest levels  observed in the  more  susceptible  models,  correlating  with  more 484 
severe lung  pathology.  This type I IFN-inducible  signature resulted from the  host 485 
genetic background and the dose and strain of M. tuberculosis, possibly explaining 486 
difering reports regarding the role of type I IFN in TB pathogenesis18,20-22,24,45,46. The 487 
enhanced type I IFN-associated signature in the C3HeB/FeJ mice is in keeping with 488 
a recent report that the B6.Sst1S congenic mice carying the C3H “sensitive” alele of 489 
the  Sst1 locus that renders them  highly  susceptible to M. tuberculosis infections47, 490 
exhibit  markedly increased type I IFN  signaling  which  contributes to their  high  TB 491 
susceptibility  via induction  of the IL-1 receptor  antagonist (IL-1Ra)48.  We  show that 492 
the Il1rn gene  expression is increased in  mouse  blood  and lung  upon infection, 493 
corelating  with increasing  susceptibility to  TB in  C3HeB/FeJ  mice infected  with 494 
HN878,  a M. tuberculosis strain reported to  enhance type I IFN induction  and  TB 495 
pathogenesis21,22. The IL1RN gene was highly expressed in blood from TB patients, 496 
but also in the LTBI-progressors, along with other type I IFN-inducible genes such as 497 
OAS1, IFITM1 and ISG15, suggesting that type I IFN-inducible genes may contribute 498 
to early TB pathogenesis. Genes of the complement cascade were also upregulated 499 
in the blood from LTBI-progressors, in keeping with previous reports15,49. 500 
Upregulation of both type I and I IFN have been reported before diagnosis of 501 
TB patients15. However, we herein report that in TB patients the IFNG gene itself is 502 
down-regulated in the blood, alongside a number of key molecules, including TBX21, 503 
EOMES,  GZMA,  GZMB,  NKG7  and  KLRD1, suggesting  a loss  of the  protective 504 
efector function of T and NK cels5,6,39,40. This decrease was also observed in LTBI-505 
progressors,  suggesting that  decreased  expression  of IFNG and  other  genes 506 
associated  with efector and cytotoxic functions early after M. tuberculosis infection 507 
may  contribute to  disease  progression.  This  supports reports that IFN-γ,  cytotoxic 508 
efector molecules and NK cels are important for protection against M. tuberculosis 509 
infection in  both  mouse  models  and  human  disease5,6,39,40. In  keeping  with this, 510 
genes associated with efector and cytotoxic NK and T cel responses (Nkg7, Klrd1, 511 
Gzma, Gzmb, Tbx21) as wel as Ifng were upregulated in the blood and lungs of M. 512 
tuberculosis infected TB resistant C57BL/6J mice but drasticaly reduced in the blood 513 
and lungs from  HN878 infected  susceptible  C3HeB/FeJ  mice,  similarly to in  blood 514 
from  LTBI-progressors  and  active  TB  patients.  Decreased IFNG  expression in the 515 
blood of TB patients and Ifng expression in the blood and lungs of susceptible mice 516 
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paralels the increase in neutrophils, supporting previous reports that IFN-γ regulates 517 
neutrophil function35 thus limiting lung inflammation and TB exacerbation. 518 
Our findings of a decrease in the B cel-associated modular expression in the 519 
blood of M. tuberculosis infected susceptible mice are in keeping with reports on the 520 
reduction in abundance of total B cels in human TB8,40 largely driven by a reduction 521 
in circulating naive B cels40. This under-abundance of the B cel-associated module 522 
was also observed in blood from LTBI-progressors, although maximal in TB patients 523 
and susceptible mice with advanced signs of lung disease. Reduction in peripheral B 524 
cels could be due to preferential sequestration of these cels at the site of infection 525 
or  diminished  output  of  B  cels from the  bone  marow36,37.  Our  data  support  a 526 
combination of both, depending on the extent of the disease. The top 50 interacting 527 
“hub”  genes in the  B  cel-associated  module  showed increased  expression in the 528 
lungs from M. tuberculosis infected resistant mice , but were decreased in lungs from 529 
HN878 infected susceptible mice, as verified by histopathology. B cels at the site of 530 
infection could be contributing to control of M. tuberculosis infection in the resistant 531 
mice as has been proposed36,37. 532 
Using a combination of mouse TB models and human TB cohorts we provide 533 
data to  suggest that  dominance  of  a type I IFN response  and  neutrophil  activation 534 
and recruitment, together with a loss of B cel, NK and T cel efector responses may 535 
contribute to the  pathogenesis  of  progressive M. tuberculosis infection.  Mouse 536 
models of TB have been employed for decades as tools for elucidating mechanisms 537 
of  host resistance  and  pathogenesis.  While failing to recapitulate  many  of the 538 
features of clinical TB and in several cases protective vaccine responses, they have 539 
been remarkably  useful in identifying  both  efector  and regulatory responses that 540 
have  emerged to  be important in  human infection  and  disease.  The  data reported 541 
here  comparing the  host transcriptomic responses  of M. tuberculosis infected  mice 542 
and  humans  ofer further  compeling  characterization  and  validation  of the  mouse 543 
model for further mechanistic studies and suggest a peripheral signature associated 544 
with progression to clinical disease in TB. 545 
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Figure legends: 743 
 744 
Figure  1. Human  TB  blood transcriptional  signature is  preserved in  blood  of 745 
TB susceptible mice. Blood modules of co-expressed genes derived using WGCNA 746 
from  human  TB  datasets in  Singhania et  al.  201818  are  shown for  blood  RNA-seq 747 
datasets from  TB  patients from  London (n=21  biologicaly independent  samples), 748 
South  Africa (n=16  biologicaly independent  samples) (both  compared to  London 749 
controls;  n=12  biologicaly independent  samples)  and  Leicester (n=53  biologicaly 750 
independent  samples) (compared to  Leicester  controls;  n=50  biologicaly 751 
independent samples) (Supplementary Table 2); human blood modules were tested 752 
in  blood  RNA-seq  datasets  obtained from  diferent  genetic  strains  of  mice 753 
(C57BL/6J, resistant;  C3HeB/FeJ,  susceptible) infected  with low  and  high  doses  of 754 
M. tuberculosis laboratory strain H37Rv or the M. tuberculosis clinical isolate HN878 755 
(n=4  biologicaly independent  samples  per  group for  H37Rv infection  and  n=5 756 
biologicaly independent samples per group for HN878 infection from one experiment 757 
per M. tuberculosis infection  as  depicted in  Supplementary  Fig.  1a),  compared to 758 
their respective  uninfected  controls (Supplementary  Table  3).  Fold  enrichment 759 
scores  derived  using  QuSAGE  are  depicted,  with red  and  blue indicating  modules 760 
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over-  or  under-abundant,  compared to the  controls.  Colour intensity  of the  dots 761 
represents the degree of perturbation, indicated by the colour scale. Size of the dots 762 
represents the relative degree  of perturbation, with the largest dot representing the 763 
highest  degree  of  perturbation  within the  plot.  Only  modules  with fold  enrichment 764 
scores  with  FDR p-value < 0.05  were  considered  significant  and  depicted  here (left 765 
and middle panels). Module name indicates biological processes associated with the 766 
genes within the module (Supplementary Table 1). C’, complement. PRR, pathogen 767 
recognition receptor.  Cel-type  associated  with  genes  within  each  module  were 768 
identified using the mouse cel-type-specific signatures from Singhania et al. 201941 769 
(right panel). Cel-type enrichment was calculated using a hypergeometric test, with 770 
only  FDR  p-value < 0.05  considered  significant  and  depicted  here (right  panel). 771 
Colour intensity represents significance of enrichment. 772 
 773 
Figure 2. Mouse lung disease modules tested in lungs from diverse mouse TB 774 
models. a, Mouse lung disease modules derived in Singhania et al. 201941 (L1-L38) 775 
tested in mouse lung TB samples from diferent genetic strains of mice (C57BL/6J, 776 
resistant;  C3HeB/FeJ,  susceptible) infected  with low  and  high  doses  of M. 777 
tuberculosis laboratory  strain H37Rv  or the M. tuberculosis clinical isolate  HN878 778 
(n=3  biologicaly independent  samples  per  group for low  dose  HN878 infection  of 779 
C3HeB/FeJ, and n=5 biologicaly independent samples per group for al other groups 780 
as  depicted in  Supplementary  Fig.  1a),  compared to their respective  uninfected 781 
controls (Supplementary  Table  4).  Red  and  blue indicate  modules  over-  or  under-782 
abundant,  compared to the  controls.  Colour intensity  of the  dots represents the 783 
degree of perturbation, indicated by the colour scale. Size of the dots represents the 784 
relative degree of perturbation, with the largest dot representing the highest degree 785 
of perturbation within the plot. Only modules with fold enrichment scores with FDR p-786 
value < 0.05 were considered significant and depicted here. GCC, glucocorticoid; K-787 
channel,  potassium  channel;  TM, transmembrane;  Ubiq,  ubiquitination. b-e,  Box 788 
plots  depicting the  module  eigengene  expression, i.e. the first  principal  component 789 
for al genes within the module, are shown for uninfected (Uninf) and M. tuberculosis 790 
infected (Low dose; High dose) C57Bl/6 and C3HeB/FeJ mice, for modules (b) Type 791 
I IFN/Ifit/Oas (L5); (c) IL-17 pathway/granulocytes (L11), Inflammation/IL-1 signaling/ 792 
Myeloid  cels (L12),  Myeloid  cels/Il1b/Tnf (L13); (d) Immunoglobulin  h/k  enriched 793 
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(L25); (e)  Cytotoxic/T  cels/ILC/Tbx21/Eomes/B  cels (L35)  and Ifng/Gbp/Antigen 794 
presentation (L7). 795 
 796 
Figure  3.  Histological  analysis  of  mouse lungs from M. tuberculosis infected 797 
mice. Representative  photomicrographs  of  hematoxylin  and  eosin (H&E)  or  Ziehl–798 
Neelsen (ZN) stained lung sections from diferent genetic strains of mice (C57BL/6J, 799 
resistant;  C3HeB/FeJ,  susceptible) infected  with low  and  high  doses  of M. 800 
tuberculosis laboratory  strain H37Rv  or the M. tuberculosis clinical isolate  HN878 801 
(n=2  biologicaly independent  samples  per  group for  H37Rv infection,  HN878-802 
infected C57BL/6J mice low dose and HN878-infected C3HeB/FeJ mice high dose, 803 
and  n=3  biologicaly independent  samples  per  group for  HN878-infected  C57BL/6J 804 
mice  high  dose  and  HN878-infected  C3HeB/FeJ  mice low  dose, from  one 805 
experiment per M. tuberculosis infection). From top to botom, scale bar represents 2 806 
mm,  200  µm  and  100  µm for  H&E  staining,  20  µm for  ZN  staining;  arows locate 807 
bacteria. 808 
 809 
Figure  4.  Gene  networks  of  specific  TB  modules in  human  blood from  TB 810 
patients,  and  blood  and lung from M. tuberculosis infected  mice. Diferential 811 
expression of genes from human blood modules Inflammasome/Granulocytes (HB3), 812 
B cels (HB15) and NK & T cels (HB21) depicting the top 50 “hub” network of genes 813 
with high intramodular connectivity found within the mouse data (i.e., mouse genes 814 
most connected with al other genes within the module), is shown for data from blood 815 
from TB patients (Leicester cohort), and blood and lungs from mice infected with M. 816 
tuberculosis, each  against their respective  controls.  An  enlarged representative 817 
network  showing  human  gene  names is  shown for  human  blood (top)  and  an 818 
enlarged representative  network  showing  mouse  gene  names is  shown for  blood 819 
samples from  C3HeB/FeJ  mice infected  with  high  dose  of  HN878 (botom).  Each 820 
gene is represented as a circular node with edges representing corelation between 821 
the  gene  expression  profiles  of the two respective  genes.  Colour  of the  node 822 
represents log2 foldchange of the gene for human blood TB samples or mouse blood 823 




Figure  5.  Histological  analysis  of  mouse lungs from M. tuberculosis infected 827 
mice for  neutrophils,  T  and  B  cels.  Representative  photomicrographs  of lung 828 
sections from  diferent  genetic  strains  of  mice (C57Bl/6, resistant;  C3HeB/FeJ, 829 
susceptible) infected  with low  and  high  doses  of M. tuberculosis laboratory  strain 830 
H37Rv  or the M. tuberculosis clinical isolate  HN878 (n=2  biologicaly independent 831 
samples  per  group for  H37Rv infection,  HN878-infected  C57BL/6J  mice low  dose 832 
and  HN878-infected  C3HeB/FeJ  mice  high  dose,  and  n=3  biologicaly independent 833 
samples  per  group for  HN878-infected  C57BL/6J  mice  high  dose  and  HN878-834 
infected  C3HeB/FeJ  mice low  dose, from  one  experiment  per M. tuberculosis 835 
infection)  depicting  neutrophils (2B10,  brown)  by immunohistochemistry  or  T (CD3 836 
positive, red)  and  B (B220  positive,  green)  cels  by immunofluorescence (nuclear 837 
staining  depicted in  blue,  DAPI).  Scale  bar represents  100 μm (top)  and  50 μm 838 
(botom) for Neutrophils, 200  μm (top) and 100 μm (botom) for T & B cels. 839 
 840 
Figure  6.  Quantitation  of  specific  blood  modular  signatures  against  extent  of 841 
lung pathology in mouse models and human TB. Box plots depicting the module 842 
Eigengene  expression for  human  blood  modules Interferon/PRR (HB12)  and 843 
Interferon/C’/Myeloid (HB23) (a, b), Inflammasome/Granulocytes (HB3)  and Innate 844 
immunity/PRR/C’/  Granulocytes (HB8) (c, d),  B  cels (HB15)  and  NK  &  T  cels 845 
(HB21) (e, f),  are  shown for  mouse  blood  samples from  uninfected (Uninf;  n  =  5 846 
biologicaly independent  samples  per  group)  and M. tuberculosis H37Rv or  HN878 847 
infected (L, low dose; H, high dose) C57Bl/6 and C3HeB/FeJ mice (n=3 biologicaly 848 
independent  samples  per  group for low  dose  HN878 infection  of  C3HeB/FeJ,  and 849 
n=5  biologicaly independent  samples  per  group for  al other  groups  as  depicted in 850 
Supplementary Fig. 1a) (a, c, e); and for human blood samples from the London TB 851 
cohort divided in Healthy Control (no X-ray; n=12 biologicaly independent samples) 852 
and  TB  patients  grouped  according to the radiographic  extent  of  disease  as  No 853 
disease (n=21  biologicaly independent  samples),  Minimal (n=7  biologicaly 854 
independent samples),  Moderate (n  =  6  biologicaly independent  samples)  or 855 
Advanced (n=8,  biologicaly independent  samples,  described in  Bery et  al.  20109) 856 
(b, d, f). Lung lesion global score (a), neutrophil (c) and lymphocyte (e) scores from 857 
H&E  stained lung  sections  are  also  shown for  uninfected (Uninf,  n=5  biologicaly 858 
independent samples  per group)  and M. tuberculosis H37Rv  or HN878 infected (L, 859 
low dose; H, high dose) C57Bl/6 and C3HeB/FeJ mice (n=2 biologicaly independent 860 
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samples  per  group for  H37Rv infection,  HN878-infected  C57BL/6J  mice low  dose 861 
and  HN878-infected  C3HeB/FeJ  mice  high  dose,  and  n=3  biologicaly independent 862 
samples  per  group for  HN878-infected  C57BL/6J  mice  high  dose  and  HN878-863 
infected  C3HeB/FeJ  mice low  dose, from  one  experiment  per M. tuberculosis 864 
infection). 865 
 866 
Figure 7. Quantitation of specific blood modular signatures in blood of healthy 867 
controls, LTBI, LTBI-progressors and active TB patients. Box plots depicting the 868 
module Eigengene expression for human blood modules Interferon/PRR (HB12) and 869 
Interferon/C’/Myeloid (HB23) (a), Inflammasome/Granulocytes (HB3)  and Innate 870 
immunity/PRR/C’/ Granulocytes (HB8) (b), B cels (HB15) and NK & T cels (HB21) 871 
(c),  are  shown for  human  blood  samples from the  Leicester  TB  cohort  divided in 872 
Control (IGRA-ve  TB  contacts  who remained  healthy;  n=50  biologicaly independent 873 
samples),  LTBI (IGRA+ve  TB  contacts  who remained  healthy;  n=49  biologicaly 874 
independent samples), LTBI_Progressor (TB contacts who developed TB, time point 875 
just before the contact was diagnosed with active TB; n=6 biologicaly independent 876 
samples) and Active_TB (patients with active disease; n=53 biologicaly independent 877 
samples) (left panels) or divided in Control – LTBI (IGRA-ve and IGRA+ve TB contacts 878 
who remained healthy) or TB patients grouped according to the radiographic extent 879 
of disease as Minimal, Moderate and Advanced (right panels; Supplementary Table 880 
7). 881 
 882 
Figure  8.  Quantitation  of IFN,  neutrophil  and lymphocyte-specific  gene 883 
expression in blood of healthy controls, LTBI, LTBI-progressors and active TB 884 
patients. Box plots depicting the log2 expression values of selected genes from type 885 
I IFN-associated modules HB12 and  HB23 (a),  neutrophil-associated modules HB3 886 
and HB8 (b) and NK & T cel module HB21 (c) are shown for human blood samples 887 
from the Leicester TB cohort divided in Control (IGRA-ve TB contacts who remained 888 
healthy;  n=50  biologicaly independent  samples),  LTBI (IGRA+ve  TB  contacts  who 889 
remained  healthy;  n=49  biologicaly independent  samples),  LTBI_Progressor (TB 890 
contacts  who  developed  TB, time point just  before the  contact  was  diagnosed  with 891 
active TB; n=6 biologicaly independent samples) and Active_TB (patients with active 892 
disease; n=53 biologicaly independent samples) (left panels) or divided in Control – 893 
LTBI (IGRA-ve  and IGRA+ve TB  contacts  who remained  healthy)  and  TB  patients 894 
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grouped according to the radiographic extent  of disease as Minimal,  Moderate and 895 
Advanced (right  panels;  Supplementary  Table  7).  Box  plots  are  also  shown for 896 
human  blood  samples  of  LTBI (non-progressors;  n=217  biologicaly independent 897 
samples)  and  LTBI_Progressor (individuals  who  developed  TB, time  point  1 to  180 898 
days before diagnosis; n=17 biologicaly independent samples) from an independent 899 











Table legends 911 
Table 1:  Granulocyte associated genes within the Inflammasome (HB3, left) and 912 
the Innate immunity/PRR/C’ (HB8, right)  modules that  are  over-expressed in the 913 
blood  of  TB  patient  cohorts from  London,  South  Africa  and  Leicester,  compared to 914 





ABCA13  DMXL2  KIF1B  NTNG2 
 AIF1  EVI2A  LCN2  OSM 
APOBR  FAS  LILRB5  PLA2G4A 
ASPRV1  FCGR3B  LPCAT2  PPP1R3D
ATP8B4  FGL2  LTF  PRTN3 
CAMP  GAS7  LY96  RNASEL 
CASP4  GPR141  MARCKS  S100A6 
CCR1  GSN  MCEMP1  SELL 
CD177  HIST1H2BC  MCTP1  SIGLEC9 
CD300A  HP  MEFV  SOCS3 
CKAP4 IL18RAP  MILR1  TFEC 
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CLEC4A IL1B  MMP8  TLR5 
CLEC4D IRAK3  NAIP  VCAN 
CLEC4E  KCNJ2  NCF1 
CLEC5A  KCTD12  NOD2  
 919 
 920 
(HB8) Innate immunity/PRR/C'*** 
ACSL1  FUT7  MXD1  REPS2 
ALOX5AP  GAB2  MYBPC3  RNF19B 
ANXA3  GLIPR2  NCF2  RRAGD 
AQP9  HCAR2  P2RX1  S100A11 
ARL11  HRH2  P2RY13  S100A8 
BCL6 IFNGR2  PADI4  S100A9 
BMX IGSF6  PGLYRP1  SIPA1L2 
BST1 ITGAM  PLBD1  SLC22A4
C1RL  JAML  PPP1R3B  STEAP4 
C5AR1  LITAF  PTPRJ  TIMP2 
CHST15  LRG1  PYGL  TLR2 
CRISPLD2  LYN  RAB31  TLR6 
ENTPD1  MMP9  RALB 
FOSL2  MNDA  RBM47  
 921 





Experimental  animals  and  ethics. C57BL/6J  and  C3HeB/FeJ  mice  were 926 
purchased from Jackson Laboratories (Bar Harbour, ME) and housed under barrier 927 
conditions in the  Animal  Biosafety  Level  3 (ABSL3) facility  at i3S,  Porto,  Portugal. 928 
Experiments were performed in accordance with recommendations of the European 929 
Union  Directive  2010/63/EU  and  approved  by  Portuguese  National  Authority for 930 
Animal  Health  – Direção  Geral  de  Alimentação  e  Veterinária. (DGAV-931 
Ref.0421/000/000/2016).  Mice  were  kept  with food  and  water  ad libitum  and 932 
humanely  euthanized  by  CO2  asphyxiation.  Every  efort  was  made to  minimize 933 
sufering. Age matched females were used in experiments. 934 
 935 
Mouse models of TB. M. tuberculosis experiments were performed under ABSL-3 936 
conditions. M. tuberculosis  H37Rv (laboratory  strain)  and  HN878 (clinical isolate) 937 
were grown to midlog phase in Middlebrook 7H9 broth supplemented with 10% oleic 938 
acid albumin dextrose complex (Difco), 0.05% Tween 80, and 0.5% glycerol before 939 
being quantified on 7H11 agar plates and stored in aliquots at −80°C. Aliquots frozen 940 
at −80°C  were then thawed (6  aliquots)  and  quantified, to  determine the 941 
concentration of the stored inocula. Mice were infected via the aerosol route using an 942 
inhalation exposure system (Glas-Col), calibrated to deliver from ∼100 to 1000 CFUs 943 
to the lung. The infection dose was confirmed by determining the number of viable 944 
bacteria in the lungs of five mice 3 days after the aerosol infection (low dose: ~100-945 
450  CFUs/lung;  high  dose:  ~700-900  CFUs/lung). Infected  mice  were  monitored 946 
regularly for signs of ilness such as wasting, piloerection and hunching. Mice were 947 
euthanized  by  CO2 inhalation  and  blood  and lung  samples from  each  group  were 948 
colected from individual mice for RNA isolation, post M. tuberculosis infection at the 949 
known  peak  of the  blood transcriptomic response,  or in the  specific  case  of the 950 
susceptible  C3HeB/FeJ  mice infected  with  HN878,  when they  showed  signs  of 951 
severe ilness (Supplementary Fig. 1a). Blood and lung samples from age matched 952 
uninfected  mice  were  colected  at the  same time  and  used  as  controls.  Lung 953 
samples from additional infected mice were colected for bacterial load determination 954 
(Supplementary  Fig. 1b)  or  histology (Figs. 3  and  5;  Supplementary  Fig.  6). 955 
Determination  of lung  bacterial load  was  performed  by  plating  serial  dilution  of the 956 
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organ  homogenate  on  Middlebrook  7H11  agar  supplemented  with  10%  oleic  acid 957 
albumin  dextrose  complex  plus  PANTA to  prevent  contamination  with  other 958 
infections. CFUs were counted after 3 weeks of incubation at 37°C, and the bacterial 959 
load per lung was calculated. 960 
 961 
Histopathological  analysis  of lung  samples. Lung tissues from M. tuberculosis 962 
infected mice were perfused and fixed in 10% neutral-bufered formalin folowed by 963 
70%  ethanol,  processed  and  embedded in  parafin,  sectioned  at  4 µm  and  stained 964 
with hematoxylin and eosin (H&E) or Ziehl-Neelsen (ZN). A single section from each 965 
tissue  was  viewed  and  scored  as  a  consensus  by three  board-certified  veterinary 966 
pathologists (S.L.P., E.H. and A.S.-B.) blinded to the groups (Supplementary Fig. 6). 967 
Presence  of M. tuberculosis  bacili  detected  by  ZN  positive  staining  was  scored  as 968 
paucibacilary  or  multibacilary  according to their  abundance in the tissue.  A  semi-969 
quantitative  scoring (0-4  points)  method  was  devised to  assess the folowing 970 
histological features: inflammatory  cels (neutrophils, lymphocytes,  plasma  cels, 971 
macrophages),  necrosis,  pleuritis  and fibrosis;  using the folowing  scale:  0 = not 972 
present,  1 = minimal,  2 = mild,  3  =  moderate,  and  4  =marked  changes.  The relative 973 
lesion burden scoring (0-5 points) was  determined using the folowing  scale: 0= no 974 
lesions,  1  = focal lesion,  2  =  multiple focal lesions,  3  =  one  or  more focal  severe 975 
lesions, 4 = multiple focal lesions that are extensive and coalesce, and 5 = extensive 976 
lesions that occupy the majority of the lung lobe. The percentage of tissue afected 977 
was  also  scored  and the lesion types  graded  as  Type I,  Type I  and  Type II  as 978 
previously  described  by Irwin et  al.50.  Representative images  of  each  group  were 979 
acquired  on  an  Olympus  BX43  microscope  using  an  Olympus  SC50  camera  and 980 
celSens Entry software (Ver. 1.18). 981 
 Lung lesion  global  score (Fig.  6a)  was  calculated  by  combining the relative 982 
lesion burden and the percentage of tissue afected, scored from H&E stained lung 983 
sections (Supplementary Fig. 6). Neutrophil and lymphocyte scores for H&E stained 984 
lung sections (Supplementary Fig. 6) were ploted in Fig. 6c and 6e, respectively. 985 
 986 
Microscopy for  neutrophils,  T  and  B  cels. Lung  sections from M. 987 
tuberculosis infected  mice  were  de-waxed  and re-hydrated  before  staining.  The 988 
neutrophil  staining  was  performed  using the  automated  equipment  Ventana 989 
Discovery  ULTRA.  Sections  were treated  with  Protease  1  at  37oC for  8  min for 990 
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antigen retrieval, incubated  with  primary  antibody  Rat  anti-mouse  2B10 (in  house 991 
clone 2B10) at 37oC for 48 min, folowed by OmniMap anti-Rt HRP (RUO) at room 992 
temperature (RT) for 12 min. For T and B cel staining, sections were microwaved for 993 
23 min (900W) with Citrate Bufer pH6 for antigen retrieval and then incubated with 994 
primary  antibodies  Rabbit  monoclonal  anti-CD3G (clone  ab134096,  Abcam)  and 995 
biotin  Rat  anti-mouse  CD45R/B220 (clone  RA3-6B2,  BD) for  1h  at  RT.  Sections 996 
were then incubated  with  donkey  anti-Rabbit IgG (H+L)  secondary  antibody  Alexa 997 
Fluor™  555 (A-31572, Invitrogen)  and  Streptavidin,  Alexa  Fluor™  488  conjugate 998 
(s32354, Invitrogen) for 45 min at RT, folowed by DAPI for 15 min at RT and Sudan 999 
Black for  20  min  at  RT.  Stained  sections  were  mounted  with  Tissue-Tek®  GlassTM 1000 
Pertex,  examined  and  scored  by two  board-certified  veterinary  pathologists (S.L.P. 1001 
and  A.S.-B).  Neutrophils  were  assessed  semi-quantitatively (based  on intensity  of 1002 
labeling) as folows: 0 = none present, 1 = low numbers, 2 = moderate numbers and 1003 
3 = high numbers. Neutrophil viability was scored as viable (which label with IHC) or 1004 
necrotic  by  assessing  which  subset  dominated the  stained tissue.  Representative 1005 
images  of  each  group  were  acquired  an  Olympus  BX43  microscope  using  an 1006 
Olympus SC50 camera and celSens Entry software (Ver. 1.18). 1007 
For  T  and  B  cel  quantification,  slides  were  scanned  using the  objective 1008 
magnification of 20x on an Olympus VS120-L100 Slide Scanner. T and B cels were 1009 
assessed  semi-quantitatively (based  on  positive labeling)  as folows:  0  =  none 1010 
present, 1 = very low numbers, 2 = low to moderate numbers, 3 = moderate to high 1011 
numbers  and  4  =  very  high  numbers.  The  T/B  cel ratio (%/%)  and  presence  of 1012 
folicles with germinal centres were also scored for each slide. 1013 
 1014 
RNA isolation. Blood  was  colected in  Tempus reagent (Life  Technologies)  at  1:2 1015 
ratio.  Total  RNA  was  extracted  using the  PerfectPure  RNA  Blood  Kit (5  PRIME). 1016 
Globin RNA was depleted from total RNA (1.5–2 µg) using the Mouse GLOBINclear 1017 
kit (Thermo Fisher Scientific). Lungs were colected in TRI-Reagent (Sigma-Aldrich). 1018 
Total RNA was extracted using the RiboPure™ Kit (Ambion). Al RNA was stored at 1019 
−80 °C until use. 1020 
 1021 
Quantity  and  quality  of  RNA  samples. Quantity  was  verified  using  NanoDrop™ 1022 
1000/8000  spectrophotometers (Thermo  Fisher  Scientific).  Quality  and integrity  of 1023 
the total  and the  globin-reduced  RNA  were  assessed  with the  HT  RNA  Assay 1024 
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Reagent  kit (Perkin  Elmer)  using  a  LabChip  GX  bioanalyser (Caliper  Life 1025 
Sciences/Perkin  Elmer)  and  assigned  an  RNA  Quality  Score (RQS)  or  RNA  6000 1026 
Pico kit (Agilent) using a BioAnalyzer 2100 (Agilent) and assigned an RNA Integrity 1027 
(RIN) score. RNA with an RQS/RIN >6 was used to prepare samples for microaray 1028 
or RNA-seq. 1029 
 1030 
Microarray. cRNA was prepared from 200 ng globin-reduced blood RNA or 200 ng 1031 
tissue total  RNA  using the Ilumina  TotalPrep  RNA  Amplification  Kit (Ambion). 1032 
Quality  was  checked  using  an  RNA  6000  Nano  kit (Agilent)  using  a  BioAnalyzer 1033 
2100 (Agilent). Biotinylated cRNA samples were randomized; 1.5 μg cRNA was then 1034 
hybridized to  Mouse  WG-6  v2.0  bead  chips (Ilumina)  according to the 1035 
manufacturer’s protocols. 1036 
 1037 
RNA-Seq. cDNA library preparation: for blood and tissues, total/globin-reduced RNA 1038 
(200 ng) was used to prepare cDNA libraries using the TruSeq Stranded mRNA HT 1039 
Library Preparation Kit (Ilumina). For cDNA library preparation of FACS sorted cels, 1040 
total  RNA (30–500 pg)  was  used to  prepare  cDNA libraries  using the  NEBNext® 1041 
Single Cel/Low Input RNA Library Prep Kit NEBNext® Multiplex Oligos for Ilumina® 1042 
#E6609 (New  England  BioLabs).  Quality  and integrity  of the tagged libraries  were 1043 
initialy  assessed  with the  HT  DNA  HiSens  Reagent  kit (Perkin  Elmer)  using  a 1044 
LabChip GX bioanalyser (Caliper Life Sciences/Perkin Elmer). Tagged libraries were 1045 
then  sized  and  quantitated in  duplicate (Agilent  TapeStation  system)  using  D1000 1046 
ScreenTape  and reagents (Agilent).  Libraries  were  normalized,  pooled  and then 1047 
clustered using the HiSeq® 3000/4000 PE Cluster Kit (Ilumina). The libraries were 1048 
imaged  and  sequenced  on  an Ilumina  HiSeq  4000  sequencer  using the  HiSeq® 1049 
3000/4000 SBS kit (Ilumina) at a minimum of 25 milion paired-end reads (75 bp/100 1050 
bp) per sample. 1051 
 1052 
Microarray data analysis. Microaray data was processed in GeneSpring GX v14.8 1053 
(Agilent Technologies). Flags were used to filter out the probe sets that did not result 1054 
in a “present” cal in at least 10% of the samples, with the “present” lower cut-of of 1055 
0.99.  Signal  values  were then  normalized  using  neqc function  with  default 1056 
parameters from limma package (v 3.38.3) in R. This function performs background 1057 
correction,  quantile  normalization  and log2 transformation  of intensity  signals.  For 1058 
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modular fold enrichment analysis, Ilumina IDs were converted to Ensembl IDs using 1059 
both the annotation file available from Ilumina and biomaRt package (2.38.0) in R. 1060 
Next, transcripts  were filtered to  select the  50%  most  variable  probes  across  al 1061 
samples. 1062 
 1063 
RNA-Seq  data  analysis. Raw  paired-end  RNA-seq  data  was  subjected to  quality 1064 
control  using  FastQC (Babraham  Bioinformatics)  and  MultiQC51. 1065 
Trimmomatic52 v0.36 was used to remove the adapters and filter raw reads below 36 1066 
bases long, and leading and trailing bases below quality 25. The filtered reads were 1067 
aligned to the Mus  musculus genome  Ensembl  GRCm38 (release  86)  using 1068 
HISAT253 v2.0.4  with  default  setings  and  RF rna-strandedness, including  unpaired 1069 
reads, resulting from Trimmomatic, using option -U. The mapped and aligned reads 1070 
were  quantified to  obtain the  gene-level  counts  using  HtSeq54 v0.6.1  with  default 1071 
setings  and reverse  strandedness.  Raw  counts  were  processed  using the 1072 
bioconductor  package  DESeq255 v1.12.4 in  R  v3.3.1,  and  normalized  using the 1073 
DESeq  method to remove the library-specific  artefacts.  Variance  stabilizing 1074 
transformation  was  applied to  obtain  normalized log2 gene  expression  values. 1075 
Further quality control was performed using principal component analysis, boxplots, 1076 
histograms  and  density  plots.  Diferentialy  expressed  genes  were  calculated  using 1077 
the  Wald test in  DESeq255.  Genes  with log2 fold  change  >1  or  <−1  and false 1078 
discovery rate (FDR) p-value < 0.05  corrected for  multiple testing  using the 1079 
Benjamini–Hochberg (BH)  method56 were  considered  significant.  Log2 fold  changes 1080 
in mouse blood, mouse lung and human blood datasets (Bery London, Bery South 1081 
Africa  and  Leicester:  GSE107995),  using the top  50 intra-modular  genes  within 1082 
selected human blood modules, were represented in heatmaps using the pheatmap 1083 
package in R (Raivo Kolde (2019). pheatmap: Prety Heatmaps. R package version 1084 
1.0.12.) (Fig.  4;  Supplementary  Fig.  8  and  9).  For lung  module  generation,  and 1085 
modular fold  enrichment,  only  protein  coding  genes  were  considered 1086 
(Supplementary Fig. 5). PCA plots were generated using prcomp function in R and 1087 
ploted  using  ggplot2  package (H.  Wickham.  ggplot2:  Elegant  Graphics for  Data 1088 
Analysis. Springer-Verlag New York, 2016.). 1089 
 1090 
Celular  deconvolution. Deconvolution  analysis for  quantification  of relative levels 1091 
of  distinct  cel types  on  a  per  sample  basis  was  carried  out  on  normalized  counts 1092 
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using CIBERSORT57. CIBERSORT estimates the relative subsets of RNA transcripts 1093 
using linear support vector regression. Mouse cel signatures for 25 cel types were 1094 
obtained using ImmuCC58 and grouped into 9 representative cel types based on the 1095 
application  of ImmuCC  celular  deconvolution  analysis to the  sorted  cel  RNA-seq 1096 
samples from the ImmGen  ULI  RNA-seq  dataset (ImmGen  Consortium: 1097 
GSE109125; htp:/www.immgen.org) as previously described31,59,60 (Supplementary 1098 
Fig. 1d). 1099 
 1100 
Module  generation. Human  blood  modules  were  previously  determined in  human 1101 
TB16. Weighted gene co-expression network analysis was performed to identify lung 1102 
modules  using the  package  WGCNA61 in  R.  Modules  were  across  al  control  and 1103 
infected  samples,  using log2 RNA-seq  expression  values.  The lung  modules  were 1104 
constructed using the 10,000 most variable genes across al lung samples. A signed 1105 
weighted corelation matrix containing pairwise Pearson corelations between al the 1106 
genes across al the samples was computed using a soft threshold of β = 22 to reach 1107 
a scale-free topology. Using this adjacency matrix, the topological overlap measure 1108 
(TOM)  was  calculated,  which  measures the  network interconnectedness62 and is 1109 
used  as input to  group  highly  correlated  genes together  using  average linkage 1110 
hierarchical clustering. The WGCNA dynamic hybrid tree-cut algorithm63 was used to 1111 
detect the network modules of co-expressed genes with a minimum module size of 1112 
20, and deep split = 1. Lung modules were numbered ML1–ML27, and human blood 1113 
modules previously found in human TB16 were numbered HB1-HB23. An additional 1114 
“grey” module was identified in lung modules (Supplementary Table 6, module titled 1115 
NA),  consisting  of  genes that  were  not  co-expressed  with  any  other  genes.  These 1116 
grey modules were not considered in any further analysis. To create gene interaction 1117 
networks,  hub  genes  with the  highest intramodular  connectivity  and  a  minimum 1118 
correlation of 0.75 were calculated, with a cut-of of 50 hub genes, and exported into 1119 
Cytoscape v3.4.0 for visualization. 1120 
For  checking  either  human  blood  modules into  mouse  data  or  mouse lung 1121 
modules into human data, human Ensembl gene ID were translated into Mouse gene 1122 
ID using BioMart to extract mouse ortholog genes (Supplementary Table 8). 1123 
 1124 
Modular  annotation. Lung  modules  were  enriched for  biological  pathways  and 1125 
processed using IPA (QIAGEN Bioinformatics), Metacore (Thomson Reuters), and a 1126 
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careful  manual  annotation,  by  checking  cel-type-specific  enrichment  and individual 1127 
read  counts.  Significantly  enriched  canonical  pathways,  and  upstream regulators 1128 
were  obtained from IPA (top  5).  Modules  were  assigned  names  based  on 1129 
representative  biological  processes from  pathways  and  processes from  al three 1130 
methods (Supplementary Table 5 and 6). 1131 
 1132 
Module  enrichment  analysis. Fold  enrichment for the  WGCNA  modules  was 1133 
calculated using the quantitative set analysis for gene expression (QuSAGE)64 using 1134 
the bioconductor package qusage v2.4.0 in R, to identify the modules of genes over- 1135 
or  under-abundant in  a  dataset,  compared to the respective  control  group  using 1136 
log2 expression values. The qusage function was used with n.points parameter set to 1137 
215. Only modules with enrichment scores with FDR p-value < 0.05 were considered 1138 
significant, and ploted using the ggcorrplot function in R. Eigengene profiles, which 1139 
are representative expression profiles for a given module in aparticular dataset, have 1140 
been  generated  using the  moduleEigengenes function from the  WGCNA  package 1141 
and have ploted using ggplot2 package. 1142 
 1143 
Cel-type-specific  enrichment. Cel-type  enrichment  analysis to identify  over-1144 
represented  cel types in  blood  and lung  modules  was  performed  as  previously 1145 
described31  using  a  hypergeometric test,  using the  phyper function in  R. p-Values 1146 
were  corrected for  multiple testing  using the  p.adjust function in  R,  using the  BH 1147 
method, to obtain FDR corrected p-values. 1148 
 1149 
Method for use of online WebApp 1150 
An online web application: htps:/ogarra.shinyapps.io/tbtranscriptome/ accompanies 1151 
the  manuscript to  visualize the findings  of the  study.  The  app is  subdivided into  4 1152 
distinct  pages that  can  be  accessed through the tabs displayed  on the top  of the 1153 
page, with a customized sidebar for user input on each page. 1154 
Tab  1: “Expression  Table”  alows the  user to visualize read  counts,  either  as raw 1155 
counts or log2 normalized expression values, in either the Mouse Blood TB, Mouse 1156 
Lung TB, Human Blood TB (Leicester, London or South Africa) datasets. Each row 1157 
represents  a  diferent  gene,  each  column  a  sample in the  corresponding  dataset. 1158 
The user can download the dataset into spreadsheet file format. 1159 
 1160 
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Tab  2: “Average  expression  Table”  alows the  user to visualize the  average read 1161 
counts by group, either as raw counts or log2 normalized expression values, in either 1162 
the Mouse Blood TB, Mouse Lung TB, Human Blood TB (Leicester, London or South 1163 
Africa) datasets. Each row represents a diferent gene, each column a group in the 1164 
corresponding  dataset.  The  user  can  download the  dataset into  spreadsheet file 1165 
format. 1166 
 1167 
Tab 3: “Gene expression” alows the user to visualize the expression of individual 1168 
genes,  either  as raw  or log2  normalized  expression  values, in  either the  Mouse 1169 
Blood  TB,  Mouse  Lung  TB,  Human  Blood  TB (Leicester,  London  or  South  Africa) 1170 
datasets.  Each  dot represents the  expression  value for the  chosen  gene, in  one 1171 
sample. 1172 
 1173 
Tab  4: “Module  profiles” alows the  user to  visualize the  expression  profile 1174 
(EigenGene from  WGCNA  R  package),  of  a  module  he  can  select,  either from 1175 
Human  Blood  TB  Modules (HB1-HB23)16,  Mouse  Lung  TB  modules (ML1–ML27) 1176 
derived de novo in this study, or Mouse Lung Disease modules (L1-L38)31. Each dot 1177 
represents the  EigenGene  value for the  chosen  module, in  one  sample.  A table 1178 
below the plot displays al genes present within that module. 1179 
 1180 
Reporting Summary 1181 
Further information  on research  design is  available in the Life  Sciences  Reporting 1182 
Summary. 1183 
 1184 
Data availability 1185 
The  materials,  data  and  any  associated  protocols that  support the findings  of this 1186 
study  are  available from the  coresponding  author  upon request.  The  RNA-seq 1187 
datasets  have  been  deposited in the  NCBI  Gene  Expression  Omnibus (GEO) 1188 
database  with the  primary  accession  number GSE140945 (TB  mouse  blood  and 1189 
lung). Publicly available datasets used in this study include GSE107995 (human TB 1190 
datasets from Singhania et al. 201818) and GSE79362 (human TB dataset from Zak 1191 
et al. 201619). 1192 
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